Liudmila Alexandrova | Biology and Life Sciences | Research Excellence Award

Dr. Liudmila Alexandrova | Biology and Life Sciences | Research Excellence Award

EIMB RAS | Russia

Liudmila A. Alexandrova is a senior researcher at the Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, with a distinguished career spanning several decades in molecular biology and medicinal chemistry. She received her education from Lomonosov Moscow State University and completed her postgraduate training at EIMB RAS. An Alexander von Humboldt Foundation, she has gained extensive international research experience through postdoctoral work in Czechoslovakia and Germany. Her scientific contributions include the design and synthesis of biologically active modified nucleosides and nucleotides, with a strong focus on antiviral, antibacterial, and antifungal drug mechanisms. She has authored more than 100 peer-reviewed publications and holds five Russian patents, reflecting a substantial body of documented research output.  She has successfully supervised four PhD dissertations and over 35 diploma theses, while currently mentoring postgraduate researchers. Recipient of two Russian Academy of Sciences awards, her work has significantly advanced the development of novel bacterial and fungal growth inhibitors, establishing her as a respected contributor to biomedical and chemical research with lasting scientific influence.

Citation Metrics (Google Scholar)

2000
1200
600
200
0

Citations
987

Document
89
h-index
19

Citations

Documents

h-index


View Google Scholar Profile

Featured Publications


The synthesis and antituberculosis activity of 5′-nor carbocyclic uracil derivatives
E. Matyugina, A. Khandazhinskaya, L. Chernousova, S. Andreevskaya, Bioorganic & Medicinal Chemistry, 20(22), 6680–6686, 2012. (Citations: 82)


Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides
E.R. Shmalenyuk, L.N. Chernousova, I.L. Karpenko, S.N. Kochetkov, Bioorganic & Medicinal Chemistry, 21(17), 4874–4884, 2013. (Citations: 72)


2′-Deoxynucleoside 5′-triphosphates modified at α-, β- and γ-phosphates as substrates for DNA polymerases
L.A. Alexandrova, A.Y. Skoblov, M.V. Jasko, L.S. Victorova, A.A. Krayevsky, Nucleic Acids Research, 26(3), 778–786, 1998. (Citations: 68)


Oligonucleotide derivatives bearing reactive and stabilizing groups attached to C5 of deoxyuridine
A.S. Levina, D.R. Tabatadse, L.M. Khalimskaya, T.A. Prichodko, G.V. Shishkin, Bioconjugate Chemistry, 4(5), 319–325, 1993. (Citations: 49)


Colorimetric solid-phase minisequencing assay illustrated by detection of alpha 1-antitrypsin Z mutation
L. Harju, T. Weber, L. Alexandrova, M. Lukin, M. Ranki, A. Jalanko, Clinical Chemistry, 39(11), 2282–2287, 1993. (Citations: 47)

Kevin Clark | Neuroscience | Research Excellence Award

Dr. Kevin Clark | Neuroscience | Research Excellence Award

Oregon State Universitys |United States

Kevin B. Clark, Ph.D., is a neuroscientist and interdisciplinary researcher with extensive experience spanning behavioral neuroscience, neuropsychology, computational biology, and translational science. He received advanced academic training at Oregon State University, Southern Illinois University, and the Max Planck Institute for Biological Cybernetics, where his work integrated psychology, physiology, and cognitive systems research. His professional career includes long-term service as a postdoctoral fellow, laboratory coordinator, and research scientist across academic, federal, and international research institutions, including the Veterans Affairs Healthcare System and the Max Planck Society. Dr. Clark has held senior leadership and advisory roles in scientific foundations, biotechnology consulting, conservation science, astrobiology, and advanced computing initiatives supported by organizations such as NASA, NSF, IEEE, and the National Academies of Sciences. His research interests focus on neural systems, cognitive processing, neurolinguistics, complex biological systems, neurotechnology, and data-driven approaches to understanding behavior and disease. His scholarly output, as reflected in Google Scholar metrics, includes a sustained record of peer-reviewed publications, cumulative citations, and a measurable h-index demonstrating long-term research impact. Dr. Clark’s career reflects a unique synthesis of scientific innovation, mentorship, and cross-sector collaboration, contributing to both fundamental neuroscience and applied societal challenges.

Citation Metrics (Scopus)

1200
1000
600
200
0

Citations
61

Documents
1
h-index
1

Citations

Documents

h-index


View Scopus Profile

Featured Publications